Outcomes of Catheter Ablation of Ventricular Tachycardia in the Setting of Structural Heart Disease.

about

Extracorporeal life support for refractory ventricular tachycardia Ablation Outcomes and Predictors of Mortality Following Catheter Ablation for Ventricular Tachycardia: Data From the German Multicenter Ablation Registry.

P2860

Q30399667-F1BF2C32-E5B0-4E80-BE8D-EAF7E0EEFB85 Q52639477-94E1CD64-1A5C-4D8D-88AE-3ADAA811CB93

P2860

Outcomes of Catheter Ablation of Ventricular Tachycardia in the Setting of Structural Heart Disease.

Item

http://www.wikidata.org/entity/Q38846518

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Outcomes of Catheter Ablation ...... g of Structural Heart Disease.

@en

type

Item

label

Outcomes of Catheter Ablation ...... g of Structural Heart Disease.

@en

prefLabel

Outcomes of Catheter Ablation ...... g of Structural Heart Disease.

@en

P1476

Outcomes of Catheter Ablation ...... g of Structural Heart Disease.

@en

P2093

B P Betensky

http://www.w3.org/2001/XMLSchema#string

F E Marchlinski

http://www.w3.org/2001/XMLSchema#string

P2860

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.

Arrhythmogenic right ventricular dysplasia: a United States experience.

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Dev

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolo

Endocardial unipolar voltage mapping to detect epicardial ventricular tachycardia substrate in patients with nonischemic left ventricular cardiomyopathy

Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study.

P2888

s11886-016-0742-9

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11886-016-0742-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1047168136

http://www.w3.org/2001/XMLSchema#string

P698

27234813

http://www.w3.org/2001/XMLSchema#string

P921

catheter ablation

Outcomes of Catheter Ablation of Ventricular Tachycardia in the Setting of Structural Heart Disease.

about

P2860

P2860

Outcomes of Catheter Ablation of Ventricular Tachycardia in the Setting of Structural Heart Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921